If You Invested in Astrana Health Inc. (ASTH)
Looking for the current price? See the ASTH quote & overviewWhat $1,000 or $10,000 in ASTH Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Nov 16, 2015 |
|---|---|---|---|---|
| $1,000 | $1,477 +48% | $267 -73% | $7,067 +607% | $4,543 +354% |
| $10,000 | $14,770 +48% | $2,670 -73% | $70,667 +607% | $45,429 +354% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-13. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for ASTH$1,000 Investment Over Time
ASTH vs S&P 500Year-by-Year Returns
ASTH annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015Nov 16 to Dec 31 | $7.00 | $4.75 | -32.1% | -32.1% |
| 2016 | $4.75 | $7.50 | +57.9% | +7.1% |
| 2017 | $7.50 | $24.00 | +220.0% | +242.9% |
| 2018 | $24.00 | $19.85 | -17.3% | +183.6% |
| 2019 | $19.85 | $18.41 | -7.3% | +163.0% |
| 2020 | $18.41 | $18.27 | -0.8% | +161.0% |
| 2021 | $18.27 | $73.48 | +302.2% | +949.7% |
| 2022 | $73.48 | $29.59 | -59.7% | +322.7% |
| 2023 | $29.59 | $38.30 | +29.4% | +447.1% |
| 2024 | $38.30 | $31.53 | -17.7% | +350.4% |
| 2025 | $31.53 | $24.81 | -21.3% | +254.4% |
| 2026Dec 31, 2025 to Nov 13 | $24.81 | $31.80 | +28.2% | +354.3% |
About Astrana Health Inc.
Healthcare · NASDAQ
Astrana Health, Inc. (NASDAQ: ASTH) is described as a physician-centric, AI-powered and technology-enabled healthcare company that supports providers in delivering high-quality, patient-centered care. According to the company’s public statements, Astrana is focused on making care more accessible, coordinated, and high-value by combining a scalable care delivery infrastructure, a proprietary technology platform, and aligned provider networks.
Astrana operates in the healthcare sector and is associated with the medical care facilities and population health management space. The company characterizes itself as patient-centered and physician-centric, with an emphasis on proactive, preventive care delivered at scale. Its model is built from the physician’s perspective, aiming to improve patient outcomes, enhance patient experiences, support provider well-being, and create greater value across the healthcare system.
Business model and segments
Based on available information, Astrana is an integrated population health management company. It focuses on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company reports three segments: Care Partners, Care Delivery, and Care Enablement. Astrana has stated that it generates the majority of its revenue from the Care Partners segment.
Through its affiliated provider networks, management services organization, and integrated care delivery clinics that span primary, specialty, and ancillary care, Astrana supports value-based care arrangements. Public disclosures note that Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements. Earlier company descriptions referenced support for more than 12,000 providers and over one million patients, indicating that Astrana has expanded the scale of its operations over time.
Technology platform and AI focus
Astrana describes its platform as both technology-enabled and AI-powered. The company highlights a proprietary, end-to-end technology platform that is designed to empower providers to deliver more proactive and preventive care. Astrana associates this platform with real-time visibility into patients’ health, longitudinal patient relationships, and value-based care operations. In its public communications, Astrana links its use of automation and AI to operational efficiency and to supporting clinical and care management capabilities.
Value-based care and population health
The company emphasizes value-based care arrangements as a core part of its business. Astrana states that it supports providers and patients in value-based arrangements across multiple lines of business, including Medicare Advantage, Medicaid, and Commercial products, particularly through its networks and acquired businesses. Its population health management approach is described as coordinated and outcomes-based, with a focus on controlling medical cost trends while maintaining or improving quality and outcomes.
According to company materials, Astrana’s affiliated networks and clinics span primary care, specialty care, and ancillary services. Within this framework, Astrana’s Care Partners, Care Delivery, and Care Enablement segments relate to provider networks, care delivery sites, and enabling services and technology that support value-based care and delegated risk models.
Prospect Health acquisition and expanded footprint
On July 1, 2025, Astrana completed the acquisition of Prospect Health, a value-based integrated care delivery network. Prospect Health has been described as coordinating the delivery of high-quality care through a network of over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island in its medical groups. Prospect Health serves approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business and operates a California Restricted Knox-Keene-licensed health plan, a management services organization, a specialty pharmacy, and an acute care hospital.
Astrana has stated that the acquisition of Prospect Health is intended to deepen its capabilities in providing access to high-quality and high-value care and to expand its scale, capabilities, and physician reach across key markets. Subsequent company communications refer to combined operations with Prospect Health and integration efforts that are intended to expand Astrana’s care delivery platform.
Provider networks and care delivery infrastructure
Across its operations, Astrana reports that it supports providers through affiliated provider networks and a management services organization. The company also references integrated care delivery clinics that cover primary, specialty, and ancillary care. These elements form a care delivery infrastructure that Astrana associates with coordinated care, value-based arrangements, and delegated models where it manages aspects of medical cost and care quality.
In addition to its own networks and clinics, Astrana has highlighted partnerships with other health systems and provider groups. For example, the company has publicly announced a strategic partnership with Intermountain Health to expand access to coordinated care in southern Nevada by integrating Astrana’s provider network and clinics with Intermountain’s health system capabilities. Astrana has also disclosed partnerships with provider groups in Southern California within its Care Enablement business.
Financial reporting and growth orientation
Astrana is a public company that files reports with the U.S. Securities and Exchange Commission and trades on NASDAQ under the symbol ASTH. The company issues quarterly earnings releases and related Form 8-K filings that describe its financial results, segment performance, and guidance. In these communications, Astrana frequently references revenue and adjusted EBITDA, as well as medical cost trends and performance across its Care Partners, Care Delivery, and Care Enablement segments.
Company statements link its financial performance to the scale of its provider and patient base, the effectiveness of its value-based care model, and integration of acquired entities such as Collaborative Health Systems and Prospect Health. Astrana also notes the use of a term loan credit facility in connection with the Prospect Health acquisition and has discussed net leverage targets in its public disclosures.
Corporate communications and investor engagement
Astrana regularly participates in healthcare and investor conferences, including events hosted by J.P. Morgan, Wells Fargo, Morgan Stanley, Baird, and William Blair. The company uses these events, along with conference calls and webcasts, to discuss its financial results, strategy, and operations. Astrana also furnishes investor presentations via Form 8-K and maintains an investor relations calendar where it posts webcast links and presentation materials.
Similar Stocks
See how related companies performed
Frequently Asked Questions
Astrana Health Inc. investment returns
How much would $1,000 invested in Astrana Health Inc. be worth today?
If you invested $1,000 in Astrana Health Inc. (ASTH) 10 years ago on 2016-11-14, your investment would be worth $7,067 as of 2026-11-13, a +606.7% price return without dividends, growing at a compounded rate of 21.6% per year (CAGR).
Has Astrana Health Inc. outperformed the S&P 500?
Over the past 10 years, ASTH returned +606.7% compared to +248.3% for the S&P 500, outperforming the benchmark by 358.4 percentage points.
What is Astrana Health Inc.'s average annual return?
The compound annual growth rate (CAGR) of ASTH’s share price over the past 10 years is 21.6%, without dividends. Individual years vary a great deal, and ASTH’s best recent full year was 2021 (+302.2%) while the worst was 2022 (-59.7%).
For informational and educational purposes only, not investment advice.